Multifaceted role of redox pattern in the tumor immune microenvironment regarding autophagy and apoptosis

Yuqing Ren1,2, Ruizhi Wang1, Siyuan Weng1

  • 1Department of Interventional Radiology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, Henan, China.

Molecular Cancer
|August 10, 2023
PubMed

Insights

Disruptions in redox homeostasis, involving reactive oxygen species (ROS), are linked to cancer. This study explores how ROS impacts apoptosis, autophagy, and anti-tumor immunity within the tumor microenvironment.

Area of Science:

  • Biochemistry
  • Cell Biology
  • Immunology

Background:

  • Redox homeostasis is a critical signaling pathway influencing physiological responses.
  • Imbalances in redox homeostasis, particularly reactive oxygen species (ROS) levels, are implicated in cancer development and progression.
  • The tumor microenvironment (TME) involves complex interactions between immunity, cell death (apoptosis, autophagy), and ROS.

Purpose of the Study:

  • To investigate the mechanisms by which multi-source ROS influences apoptosis, autophagy, and anti-tumor immunity in the TME.
  • To elucidate the crosstalk between ROS, apoptosis, autophagy, and anti-tumor immune responses.
  • To examine the relationship between conventional cancer therapies and ROS, and explore potential ROS-targeted treatments.

Main Methods:

  • The study will analyze the role of ROS in regulating apoptosis and autophagy within the TME.
  • Investigate the impact of ROS on anti-tumor immune responses.
  • Examine the interplay between ROS, cell death pathways, and immune evasion in cancer.

Main Results:

  • ROS levels and species significantly affect cell fate, immune capacity, and regulatory cell death (apoptosis and autophagy) in the TME.
  • A complex crosstalk exists between ROS, apoptosis, autophagy, and anti-tumor immunity.
  • ROS plays a crucial role in modulating the efficacy of traditional cancer therapies.

Conclusions:

  • Understanding ROS-mediated regulation of apoptosis, autophagy, and immunity in the TME is vital for cancer therapy.
  • ROS-targeted strategies hold promise for novel cancer treatment approaches.
  • Further research into the intricate role of ROS in cancer is warranted.

Related Concept Videos

Autophagic Cell Death01:18

Autophagic Cell Death

Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
3.5K
Autophagy01:27

Autophagy

Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
4.3K
Phagocytosis of Apoptotic Cells01:17

Phagocytosis of Apoptotic Cells

Cells undergoing apoptosis form apoptotic bodies that must be removed immediately to prevent inflammation, autoimmune diseases, and necrosis. Phagocytosis is carried out by professional phagocytes such as macrophages or  immature dendritic cells. Non-professional phagocytes such as  epithelial cells and fibroblasts also take part in this process; however, they are not as effective as professional phagocytes. 
Normal cells contain receptors that prevent them from being recognized...
3.9K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K
Delivery Pathways to the Lysosome01:36

Delivery Pathways to the Lysosome

Eukaryotic cells use different mechanisms to eliminate toxic waste obsolete and worn-out substances. Lysosomes play a pivotal role in this, and hence, these substances are carried to the lysosome from other parts of the cell and extracellular space through different pathways. The most elaborately studied pathways to the lysosome are the endocytic pathways.
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
6.6K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.6K